跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPROXEN SODIUM TABLETS USP 220 MG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NAPROXEN SODIUM TABLETS USP 220 MG
Authorized
STANDARD
NAPROXEN SODIUM TABLETS USP 220 MG
RPG LIFE SCIENCES LIMITED
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
db739e2cda69f898
Company
RPG LIFE SCIENCES LIMITED
Type
Standard
Approval Details
Approval Id
db739e2cda69f898
Drug Approval Canada Name
NAPROXEN SODIUM TABLETS USP 220 MG
Product Name
NAPROXEN SODIUM TABLETS USP 220 MG
Status
Approved
Status Date
2025-10-03
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
NON-PRESCRIPTION DRUGS
Ahfs
28:08.04.92
Atc Original
M01AE02 NAPROXEN
Aig Number
0113934003
Company Name
RPG LIFE SCIENCES LIMITED
Company Address
3102/A, Gidc Estate, Ankleshwar Bharuch Gujarat India
Company Detail Path
/organization/rpg-life-sciences-limited
Company Information
Pharmaceutical Company Name
RPG LIFE SCIENCES LIMITED
Country Name
India
Province Name
Maharashtra
City Name
mumbai,maharashtra,country_in
Address
463, 4th Floor, RPG House
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
db739e2cda69f898
Type
Standard
Back to Health Canada Approvals